NEW YORK (GenomeWeb News) — InforSense and Ingenuity today said that customers who have licensed InforSense’s KDE platform and Igenuity’s IPA pathways-analysis software will be able to use newly developed IPA nodes along with their existing KDE workflows.

InforSense said this will enable customers to “enhance and expand” IPA functions and allow them to view genetic information taken from a KDE workflow.

Ingenuity Systems has also joined the InforSense Open Workflow Partner Network.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.